先天性出血性疾病：血友病和血管性血友病

Med Clin North Am. 1984 May;68(3):601-15. doi: 10.1016/s0025-7125(16)31118-x.

Treatment of hemophilia and von Willebrand's disease has become easier in recent years because of the development of more effective factor replacement products. The median age and the life expectancy of patients with hemophilia have risen markedly, as has the median age at death.

近年来，由于更有效的凝血因子替代产品的研发，血友病和血管性血友病的治疗变得更加容易。血友病患者的年龄中位数和预期寿命显著提高，死亡年龄中位数也有所上升。